The US Bankruptcy Court granted a first order for the extension of the exclusivity periods for PhaseBio Pharmaceuticals, Inc. on March 13, 2023. As per the order, the debtor's exclusivity period to file its plan and to solicit votes on its plan, have been extended by 90 days i.e. up to May 22, 2023 and July 20, 2023, respectively.